Table of Contents

Personalized Medicine and Imaging

• Personalized Medicine and Imaging

  Gene Expression Signatures Predictive of Bevacizumab/Erlotinib Therapeutic Benefit in Advanced Nonsquamous Non–Small Cell Lung Cancer Patients (SAKK 19/05 trial)

  Anca Franzini, Florent Baty, Ina I. Macovei, Oliver Dürr, Cornelia Droege, Daniel Betticher, Bogdan D. Grigoriu, Dirk Klingbiel, Francesco Zappa and Martin H. Brutsche

  Clin Cancer Res December 1 2015 21 (23) 5253-5263; DOI:10.1158/1078-0432.CCR-14-3135

  
  
• Personalized Medicine and Imaging

  Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium

  Sharon E. Johnatty, Jonathan P. Tyrer, Siddhartha Kar, Jonathan Beesley, Yi Lu, Bo Gao, Peter A. Fasching, Alexander Hein, Arif B. Ekici, Matthias W. Beckmann, Diether Lambrechts, Els Van Nieuwenhuysen, Ignace Vergote, Sandrina Lambrechts, Mary Anne Rossing, Jennifer A. Doherty, Jenny Chang-Claude, Francesmary Modugno, Roberta B. Ness, Kirsten B. Moysich, Douglas A. Levine, Lambertus A. Kiemeney, Leon F.A.G. Massuger, Jacek Gronwald, Jan Lubiński, Anna Jakubowska, Cezary Cybulski, Louise Brinton, Jolanta Lissowska, Nicolas Wentzensen, Honglin Song, Valerie Rhenius, Ian Campbell, Diana Eccles, Weiva Sieh, Alice S. Whittemore, Valerie McGuire, Joseph H. Rothstein, Rebecca Sutphen, Hoda Anton-Culver, Argyrios Ziogas, Simon A. Gayther, Aleksandra Gentry-Maharaj, Usha Menon, Susan J. Ramus, Celeste L. Pearce, Malcolm C. Pike, Daniel O. Stram, Anna H. Wu, Jolanta Kupryjanczyk, Agnieszka Dansonka-Mieszkowska, Iwona K. Rzepecka, Beata Spiewankiewicz, Marc T. Goodman, Lynne R. Wilkens, Michael E. Carney, Pamela J. Thompson, Florian Heitz, Andreas du Bois, Ira Schwaab, Philipp Harter, Jacobus Pisterer, Peter Hillemanns, on behalf of the AGO Study Group, Beth Y. Karlan, Christine Walsh, Jenny Lester, Sandra Orsulic, Stacey J. Winham, Madalene Earp, Melissa C. Larson, Zachary C. Fogarty, Estrid Høgdall, Allan Jensen, Susanne Kruger Kjaer, Brooke L. Fridley, Julie M. Cunningham, Robert A. Vierkant, Joellen M. Schildkraut, Edwin S. Iversen, Kathryn L. Terry, Daniel W. Cramer, Elisa V. Bandera, Irene Orlow, Tanja Pejovic, Yukie Bean, Claus Høgdall, Lene Lundvall, Ian McNeish, James Paul, Karen Carty, Nadeem Siddiqui, Rosalind Glasspool, Thomas Sellers, Catherine Kennedy, Yoke-Eng Chiew, Andrew Berchuck, Stuart MacGregor, Paul D.P. Pharoah, Ellen L. Goode, Anna deFazio, Penelope M. Webb and Georgia Chenevix-Trench

  Clin Cancer Res December 1 2015 21 (23) 5264-5276; DOI:10.1158/1078-0432.CCR-15-0632

  
  
• Personalized Medicine and Imaging

  A Phase I/II Study for Analytic Validation of ⁸⁹Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer

  Neeta Pandit-Taskar, Joseph A. O'Donoghue, Jeremy C. Durack, Serge K. Lyashchenko, Sarah M. Cheal, Volkan Beylergil, Robert A. Lefkowitz, Jorge A. Carrasquillo, Danny F. Martinez, Alex Mak Fung, Stephen B. Solomon, Mithat Gönen, Glenn Heller, Massimo Loda, David M. Nanus, Scott T. Tagawa, Jarett L. Feldman, Joseph R. Osborne, Jason S. Lewis, Victor E. Reuter, Wolfgang A. Weber, Neil H. Bander, Howard I. Scher, Steven M. Larson and Michael J. Morris

  Clin Cancer Res December 1 2015 21 (23) 5277-5285; DOI:10.1158/1078-0432.CCR-15-0552

  
  
• Personalized Medicine and Imaging

  Stool Bacteriomic Profiling in Patients with Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor–Tyrosine Kinase Inhibitors

  Sumanta K. Pal, Sierra M. Li, Xiwei Wu, Hanjun Qin, Marcin Kortylewski, JoAnn Hsu, Courtney Carmichael and Paul Frankel

  Clin Cancer Res December 1 2015 21 (23) 5286-5293; DOI:10.1158/1078-0432.CCR-15-0724

  
  
• Personalized Medicine and Imaging

  Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance)

  Frank A. Sinicrope, Michelle R. Mahoney, Harry H. Yoon, Thomas C. Smyrk, Stephen N. Thibodeau, Richard M. Goldberg, Garth D. Nelson, Daniel J. Sargent and Steven R. Alberts

  Clin Cancer Res December 1 2015 21 (23) 5294-5304; DOI:10.1158/1078-0432.CCR-15-0527

  
  
• Personalized Medicine and Imaging

  EGFR Exon 18 Mutations in Lung Cancer: Molecular Predictors of Augmented Sensitivity to Afatinib or Neratinib as Compared with First- or Third-Generation TKIs

  Yoshihisa Kobayashi, Yosuke Togashi, Yasushi Yatabe, Hiroshi Mizuuchi, Park Jangchul, Chiaki Kondo, Masaki Shimoji, Katsuaki Sato, Kenichi Suda, Kenji Tomizawa, Toshiki Takemoto, Toyoaki Hida, Kazuto Nishio and Tetsuya Mitsudomi

  Clin Cancer Res December 1 2015 21 (23) 5305-5313; DOI:10.1158/1078-0432.CCR-15-1046